Fauci: Moderna's 'outstanding' vaccine results are 'as good as it gets'


Dr. Anthony Fauci, the nation's top infectious disease expert, is hailing new data on Moderna's COVID-19 vaccine candidate as "striking" and "quite impressive."
Moderna revealed on Monday that preliminary phase-three data on its coronavirus vaccine suggested that it's 94.5 percent effective. This is a far better efficacy rate than experts had been anticipating in a vaccine against COVID-19, and it comes after Pfizer recently said its COVID-19 vaccine candidate also appears to be more than 90 percent effective.
"These are obviously very exciting results," Fauci told CNN on Monday. "It's just as good as it gets — 94.5 percent is truly outstanding."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Fauci, who previously said he would "settle" for a COVID-19 vaccine that's around 70 percent effective, also told NBC's Today the data is "quite impressive," adding that after last week's news from Pfizer, "Now we have two vaccines that are really quite effective, so I think this is a really strong step forward to where we want to be."
Both vaccines will need to receive approval from the Food and Drug Administration, but Fauci told Today he anticipates vaccine doses, hopefully "from both companies," will start becoming available to high-risk individuals by the end of December. And asked whether several more COVID-19 vaccines from other companies could be on the way, Fauci said this is "quite conceivable" and that he has hope "that more than these two will also be effective."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Alchemised: how Harry Potter fanfic went mainstream
In The Spotlight Traditional publishers are signing up fan fiction authors to rewrite their ‘explosively popular’ romances for the mass market
-
Crossword: October 6, 2025
The Week's daily crossword
-
Codeword: October 6, 2025
The Week's daily codeword puzzle
-
FDA OKs generic abortion pill, riling the right
Speed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
RFK Jr. vaccine panel advises restricting MMRV shot
Speed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreak
Speed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials